Aehr Test Systems - AEHR Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aehr Test Systems in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AEHR shares.
View AEHR analyst ratings or view top-rated stocks.

1 brokerages have issued 1 year target prices for Aehr Test Systems' stock. Their AEHR share price forecasts range from $45.00 to $45.00. On average, they anticipate the company's share price to reach $45.00 in the next twelve months. This suggests a possible upside of 21.7% from the stock's current price.
View analysts price targets for AEHR or view top-rated stocks among Wall Street analysts.

Aehr Test Systems' stock was trading at $20.10 at the beginning of 2023. Since then, AEHR stock has increased by 83.9% and is now trading at $36.97.
View the best growth stocks for 2023 here.

Aehr Test Systems saw a decrease in short interest during the month of January. As of January 15th, there was short interest totaling 4,080,000 shares, a decrease of 10.9% from the December 31st total of 4,580,000 shares. Based on an average daily volume of 1,680,000 shares, the short-interest ratio is currently 2.4 days.
View Aehr Test Systems' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 30th 2023.
View our AEHR earnings forecast.

Aehr Test Systems (NASDAQ:AEHR) announced its quarterly earnings results on Thursday, January, 6th. The semiconductor company reported $0.05 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.01. The semiconductor company earned $9.61 million during the quarter. Aehr Test Systems had a net margin of 20.23% and a trailing twelve-month return on equity of 26.31%.

Aehr Test Systems issued an update on its FY 2023 earnings guidance on Thursday, January, 5th. The company provided EPS guidance of for the period. The company issued revenue guidance of $60.00 million-$70.00 million, compared to the consensus revenue estimate of $67.57 million.

1 employees have rated Aehr Test Systems Chief Executive Officer Rhea J. Posedel on Glassdoor.com. Rhea J. Posedel has an approval rating of 100% among the company's employees. This puts Rhea J. Posedel in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aehr Test Systems investors own include Arbutus Biopharma (ABUS), Co-Diagnostics (CODX), iBio (IBIO), Inovio Pharmaceuticals (INO), Palatin Technologies (PTN), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Vaxart (VXRT), Aclaris Therapeutics (ACRS) and Acasti Pharma (ACST).

Aehr Test Systems trades on the NASDAQ under the ticker symbol "AEHR."

Aehr Test Systems' stock is owned by a number of retail and institutional investors. Top institutional investors include Essex Investment Management Co. LLC (0.53%), Navellier & Associates Inc. (0.51%), Legato Capital Management LLC (0.20%), Simplex Trading LLC (0.00%), Greenwood Capital Associates LLC (0.11%) and Artemis Investment Management LLP (0.09%). Insiders that own company stock include Alistair N Sporck, David Fucci, David S Hendrickson, Donald P Richmond II, Gayn Erickson, Geoffrey Gates Scott, Howard T Slayen, Kenneth B Spink, Kenneth B Spink, Kunio Sano, Laura Oliphant, Mario M Rosati, Michael A Brannan, Rhea J Posedel, Rhea J Posedel and Vernon Rogers.
View institutional ownership trends.

Shares of AEHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AEHR stock can currently be purchased for approximately $36.97.

Aehr Test Systems (NASDAQ:AEHR) has a market capitalization of $1.03 billion and generates $50.83 million in revenue each year. The semiconductor company earns $9.45 million in net income (profit) each year or $0.43 on an earnings per share basis.

Aehr Test Systems' mailing address is 400 KATO TERRACE, FREMONT CA, 94539. The official website for the company is www.aehr.com. The semiconductor company can be reached via phone at (510) 623-9400, via email at aehr@mkr-group.com, or via fax at 510-623-9450.